Harding Loevner’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,452,716	Closed	-$111M	–	73
2023 Q4	$111M	Sell	1,452,716 -23,843	-2%	-$1.66M	0.62%	54
2023 Q3	$102M	Sell	1,476,559 -217,390	-13%	-$17.5M	0.68%	52
2023 Q2	$160M	Sell	1,693,949 -332,877	-16%	-$28.9M	0.93%	43
2023 Q1	$168M	Sell	2,026,826 -15,731	-0.8%	-$1.24M	0.95%	43
2022 Q4	$152M	Buy	2,042,557 +216,804	+12%	+$16.7M	0.88%	44
2022 Q3	$151M	Sell	1,825,753 -98,129	-5%	-$9.44M	0.99%	37
2022 Q2	$183M	Sell	1,923,882 -51,652	-3%	-$5.35M	1.13%	29
2022 Q1	$189M	Sell	1,975,534 -131,560	-6%	-$14.8M	1.04%	36
2021 Q4	$273M	Sell	2,107,094 -43,146	-2%	-$5.03M	1.05%	38
2021 Q3	$243M	Sell	2,150,240 -78,314	-4%	-$8.94M	0.97%	35
2021 Q2	$231M	Sell	2,228,554 -8,120	-0.4%	-$765K	0.87%	42
2021 Q1	$187M	Sell	2,236,674 -168,889	-7%	-$14.3M	0.73%	49
2020 Q4	$219M	Buy	2,405,563 +2,404,717	+284,246%	+$199M	0.91%	42
2020 Q3	$68K	Hold	846	–	–	﹤0.01%	125
2020 Q2	$58K	Buy	+846	New	+$60.1K	﹤0.01%	100